Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.
Histamine and Immune Biomarkers in CNS Disorders.
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Cortical functional modifications following optic neuritis.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Olfactory dysfunction in patients with multiple sclerosis.
Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.

Pages